News

San Diego-The 2009 annual meeting of the American Glaucoma Society (AGS) is experiencing record-setting total attendance, according to officers of the organization, with 619 members and an additional 75 attendees participating. This number represents an increase of more than 20% in total attendance over last year's annual meeting.

March is Age-Related Macular Degeneration (AMD) Awareness Month, and the American Academy of Ophthalmology (AAO), the American Society of Retina Specialists, the Macula Society, and the Retina Society have teamed up to encourage Americans to become more aware of their risks for AMD.

Physicians can receive a 2% bonus for e-prescribing and participating in the Physician's Quality Reporting Initiative, adding up to a potential 4% bonus to participating doctors in 2009. This year, program participation is not mandatory, but in 2012, physicians will be penalized –1% for not e-prescribing.

Federal regulators have judged the first phase of the Medicare Recovery Audit Contractor (RAC) program a success, but the controversial plan promises potential headaches for physicians as it goes forward. In response to the initial success, the Centers for Medicare & Medicaid Services announced in October its plan to expand the program to a dozen new states in the first quarter of 2009. By January 2010, all 50 states will be in RAC's crosshairs.

No existing scientific evidence validates the presumption that thinner preoperative corneal thickness independently increases the risk of post-LASIK ectasia, as long as intraoperative pachymetry is performed to guard against a thicker-than-expected flap. In fact, thin corneas in eyes with normal topography appear to be biomechanically strong. Routine preoperative topographic screening should be performed to detect abnormalities that suggest an increased risk for post-LASIK ectasia.

Results obtained with wavefront-optimized LASIK are equivalent to those achieved with wavefront-customized LASIK, according to a retrospective study of 148 patients. The wavefront-optimized approach also presents an option for the approximately one-third of patients who cannot undergo customized treatment for one of several reasons, according to the ophthalmologist who conducted the research.

Difluprednate ophthalmic emulsion 0.05% (Durezol, Sirion Therapeutics) was comparable with prednisolone ophthalmic suspension 1% (Pred Forte, Allergan), the current standard of care, in a pivotal anterior uveitis trial. Difluprednate was dosed four times daily compared with eight times for prednisolone acetate, suggesting that it could enhance compliance.

When capsulorrhexis becomes complicated by a radial tear, pulling the flap backward, first circumferentially and then centrally, can rescue the tear-out. Here, an ophthalmologist shares a technique to successfully address this complication.

Napa and Sonoma counties, located approximately an hour from San Francisco, are well known around the United States and the world for their superior wine and wineries. Here is just a sampling of the local vineyards.

San Francisco has cuisine to satisfy many taste buds. From dim sum to gnocchi, use this guide to map out your dining tour of the city by the bay.

San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and household income are among the top in the nation, which enables a profitable restaurant and entertainment scene.

Soft Plug Flow Control Silicone Plugs (Oasis Medical) provide partial occlusion of the puncta with limited tear drainage for patients with moderate and severe dry eye. These plugs eliminate epiphora in patients for whom total occlusion is excessive.

Results from visual acuity testing, refraction, and corneal topography analysis using Scheimpflug imaging (Pentacam, Oculus) in a series of 48 eyes with progressive keratoconus demonstrate the benefits of corneal collagen crosslinking for halting keratoconus progression. More research is needed to provide answers to questions about the long-term stability of collagen corneal crosslinking and to refine its indications and contraindications.

The Joint Commission on Allied Health Personnel in Ophthalmology announced in a prepared statement that it has received approval for a separate occupational classification, ophthalmic medical technician, from the U.S. Bureau of Labor's 2010 Standard Occupational Classification committee.

Dyax Corp. and Fovea Pharmaceuticals have entered into an exclusive license agreement for the development and commercialization of an ocular formulation of DX-88 for the treatment of retinal diseases, the companies announced in a joint statement.